Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma.

MLA

Wang, Hongsheng, et al. “Disrupting YAP1-Mediated Glutamine Metabolism Induces Synthetic Lethality alongside ODC1 Inhibition in Osteosarcoma.” Cellular Oncology (2211-3428), vol. 47, no. 5, Oct. 2024, pp. 1845–61. EBSCOhost, https://doi.org/10.1007/s13402-024-00967-1.

APA

Wang, H., Tao, Y., Han, J., Shen, J., Mu, H., Wang, Z., Wang, J., Jin, X., Zhang, Q., Yang, Y., Lin, J., Sun, M., Ma, X., Ren, L., LeBlanc, A. K., Xu, J., Hua, Y., & Sun, W. (2024). Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma. Cellular Oncology (2211-3428), 47(5), 1845–1861. https://doi.org/10.1007/s13402-024-00967-1

Chicago

Wang, Hongsheng, Yining Tao, Jing Han, Jiakang Shen, Haoran Mu, Zhuoying Wang, Jinzeng Wang, et al. 2024. “Disrupting YAP1-Mediated Glutamine Metabolism Induces Synthetic Lethality alongside ODC1 Inhibition in Osteosarcoma.” Cellular Oncology (2211-3428) 47 (5): 1845–61. doi:10.1007/s13402-024-00967-1.